Abbott Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6,803	8,522	7,616	6,896	9,882	9,799
Short-Term Investments	492	417	351	383	288	450
Cash & Short-Term Investments	7,295	8,939	7,967	7,279	10,170	10,249
Cash Growth	6.59%	12.20%	9.45%	-28.43%	-0.77%	43.38%
Accounts Receivable	8,210	7,929	6,925	6,565	6,218	6,487
Other Receivables	3,014	2,640	2,570	2,256	2,663	2,346
Total Trade Receivables	11,224	10,569	9,495	8,821	8,881	8,833
Inventory	6,989	6,488	6,194	6,570	6,173	5,157
Other Current Assets	3,014	2,640	2,570	2,256	2,663	2,346
Total Current Assets	25,508	25,996	23,656	22,670	25,224	24,239
Net Property, Plant & Equipment	12,377	37,038	33,398	32,087	29,374	28,323
Other Intangible Assets	17,875	5,526	6,647	8,815	10,454	12,739
Goodwill	35,221	24,035	23,108	23,679	22,799	23,231
Long-Term Investments	1,090	918	886	799	766	816
Other Long-Term Assets	18,358	18,422	16,459	7,097	6,033	5,212
Total Assets	110,429	86,713	81,414	73,214	74,438	75,196
Accounts Payable	4,679	4,240	4,195	4,295	4,607	4,408
Accrued Expenses	7,591	7,557	6,844	7,019	7,401	6,806
Current Portion of Long-Term Debt	4,409	3,033	1,500	1,080	2,251	754
Other Current Liabilities	1,698	1,666	1,618	1,447	1,230	1,137
Total Current Liabilities	18,377	16,496	14,157	13,841	15,489	13,105
Long-Term Debt	29,638	9,896	12,625	13,599	14,522	17,296
Other Long-Term Liabilities	9,713	7,550	6,731	6,947	7,522	8,771
Total Long-Term Liabilities	39,351	17,446	19,356	20,546	22,044	26,067
Total Liabilities	57,728	33,942	33,513	34,387	37,533	39,172
Common Stock	25,352	25,527	25,153	24,869	24,709	24,470
Treasury Stock	-16,935	-17,177	-16,844	-15,981	-15,229	-11,822
Accumulated Other Comprehensive Income	-6,312	-6,001	-7,906	-7,839	-8,051	-8,374
Retained Earnings	49,956	49,781	47,261	37,554	35,257	31,528
Total Common Shareholders' Equity	52,061	52,130	47,664	38,603	36,686	35,802
Minority Interest	640	641	237	224	219	222
Shareholders' Equity	52,701	52,771	47,901	38,827	36,905	36,024
Total Liabilities & Equity	110,429	86,713	81,414	73,214	74,438	75,196
Total Debt	34,047	12,929	14,125	14,679	16,773	18,050
Net Cash (Debt)	-26,752	-3,990	-6,158	-7,400	-6,603	-7,801
Net Cash Per Share	-15.30	-2.28	-3.52	-4.23	-3.74	-4.36
Book Value	52,061	52,130	47,664	38,603	36,686	35,802
Book Value Per Share	29.77	29.82	27.27	22.07	20.80	20.01
Tangible Book Value	-1,035	22,569	17,909	6,109	3,433	-168
Tangible Book Value Per Share	-0.59	12.91	10.25	3.49	1.95	-0.09

Updated Apr 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q